Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient with septic shock from gram-positive infection

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 5, 1998, Pages 590-593

  Iwama, H ^a   Komatsu, T ^a  

^a Central Aizu General Hospital   (Japan)

Author keywords

Endotoxin; Gram positive infection; Hemoperfusion; Immobilized polymyxin B fiber; Septic shock

Indexed keywords

DOPAMINE; ENDOTOXIN; NORADRENALIN; POLYMYXIN B;

AGED; ARTICLE; BLOOD PRESSURE; CASE REPORT; HEART OUTPUT; HEMOPERFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SEPTIC SHOCK; TECHNICAL AID; TOXIN ANALYSIS; VASCULAR RESISTANCE;

EID: 0031970703     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05172.x     Document Type: Article

References (12)

1. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994: 167: 412-417.
2. Okajima K, Uchiba M, Murakami K. Nafamostat mesilate. Cardiovascular Drug Reviews 1995: 13: 51-65.
3. Obayashi T, Tamura H, Tanaka S, Ohki M, Takahashi S, Arai M et al. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985: 149: 55-65.
4. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985: 13: 818-828.
5. Stevens LE. Gauging the severity of the surgical sepsis. Arch Surg 1983: 118: 1190-1192.
6. Skau T, Nystrom P-O, Carlsson C. Severity of illness in intra-abdominal infection. Arch Surg 1985: 120: 152-158.
7. Van-Zee KJ, Deforge LE, Fischer E, Marano MA, Kenney JS, Remick DG et al. IL-8 in septic shock, endotoxemia, and after IL-I administration. J Immunol 1991: 146: 3478-3482.
8. Ayala A, Kisala JM, Felt JA, Perrin MM, Chaudry IH. Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis? Arch Surg 1992: 127: 191-197.
9. Imanishi K, Igarashi H, Uchiyama T. Activation of murine T cells by Streptococcal pyrogenic endotoxin type A. J Immunol 1990: 145: 3170-3176.
10. Parrillo JE. Pathogenetic mechanism of septic shock. N Engl J Med 1993: 328: 1471-1477.
11. Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE et al. HA-1A sepsis study group. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: A randomized, double-blind, placebo-controlled trial. N Engl J Med 1991: 324: 429-436.
12. Hanasawa K, Tani T, Kodama M. New approach to endotoxin and septic shock by means of polymyxin B immobilized fiber. Surg Gynecol Obstet 1989: 168: 323-331.